Literature DB >> 15517481

Timing and extent of surgery in patients with familial medullary thyroid carcinoma/multiple endocrine neoplasia 2A-related RET mutations not affecting codon 634.

Oliver Gimm1, Jörg Ukkat, Barbara E Niederle, Theresa Weber, Phuong Nguyen Thanh, Michael Brauckhoff, Bruno Niederle, Henning Dralle.   

Abstract

In hereditary medullary thyroid carcinoma (MTC), recommendations regarding timing and extent of surgery are mainly based on the data of patients with the codon 634 RET mutation, which is the most often affected codon. Little is known about whether these recommendations may also be applied to patients with less common RET mutations. We ascertained the data from 140 patients with FMTC/MEN2A-related RET mutation not affecting codon 634 who have been treated at three specialized centers. The several RET mutations found affected codons 611 (n = 17), 618 (n = 22), 620 (n = 17), 768 (n = 9), 790 (n = 24), 791 (n = 21), 804 (n = 23), and 891 (n = 7). For each codon, the age of the youngest patient with MTC only (41, 7, 18, 29, 13, 47, 20, and 15 years, respectively), MTC with lymph node metastases (46, 24, 21, 34, 46, 47, 50, and 76 years, respectively), and MTC with distant metastases (52, 69, 43, 68, 57, - , - , and 75 years, respectively) was determined. All patients with lymph node metastases had elevated basal calcitonin levels. Based on these data, a more individual recommendation regarding timing and extent of surgery can be given. Because neither gender nor the type of nucleotide substitution for a specific codon appeared to have a significant influence on the age of onset, this recommendation should be based on the affected codon, the age of the patient, and the calcitonin level. Recurrent laryngeal nerve palsy (n = 6) and hypoparathyroidism (n = 3) were rather rare and were found only in patients older than 30 and 43 years, respectively, giving evidence that surgery in young patients can be performed safely.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15517481     DOI: 10.1007/s00268-004-7640-9

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  39 in total

1.  Atypical MEN type 2B associated with two germline RET mutations on the same allele not involving codon 918.

Authors:  Fred H Menko; Rob B van der Luijt; Irene A J de Valk; Arno W F T Toorians; Jan M Sepers; Paul J van Diest; Cornelis J M Lips
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

2.  Various penetrance of familial medullary thyroid carcinoma in patients with RET protooncogene codon 790/791 germline mutations.

Authors:  Guido Fitze; Mandy Schierz; Jan Bredow; Hans D Saeger; Dietmar Roesner; Hans K Schackert
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

Review 3.  Guidelines for diagnosis and therapy of MEN type 1 and type 2.

Authors:  M L Brandi; R F Gagel; A Angeli; J P Bilezikian; P Beck-Peccoz; C Bordi; B Conte-Devolx; A Falchetti; R G Gheri; A Libroia; C J Lips; G Lombardi; M Mannelli; F Pacini; B A Ponder; F Raue; B Skogseid; G Tamburrano; R V Thakker; N W Thompson; P Tomassetti; F Tonelli; S A Wells; S J Marx
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

4.  Polymorphisms G691S/S904S of RET as genetic modifiers of MEN 2A.

Authors:  Mercedes Robledo; Laura Gil; Marina Pollán; Arancha Cebrián; Sergio Ruíz; Marta Azañedo; Javier Benitez; Javier Menárguez; José M Rojas
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

5.  Complications of neck dissection for thyroid cancer.

Authors:  W Keat Cheah; Cumhur Arici; Philip H G Ituarte; Allan E Siperstein; Quan-Yang Duh; Orlo H Clark
Journal:  World J Surg       Date:  2002-06-06       Impact factor: 3.352

6.  Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

Authors:  L M Mulligan; J B Kwok; C S Healey; M J Elsdon; C Eng; E Gardner; D R Love; S E Mole; J K Moore; L Papi
Journal:  Nature       Date:  1993-06-03       Impact factor: 49.962

7.  Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma.

Authors:  H Dralle; I Damm; G F Scheumann; J Kotzerke; E Kupsch; H Geerlings; R Pichlmayr
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

8.  RET proto-oncogene mutations affecting codon 790/791: A mild form of multiple endocrine neoplasia type 2A syndrome?

Authors:  Oliver Gimm; Barbara E Niederle; Theresa Weber; Maximilian Bockhorn; Jörg Ukkat; Michael Brauckhoff; Phuong Nguyen Thanh; Andreja Frilling; Ernst Klar; Bruno Niederle; Henning Dralle
Journal:  Surgery       Date:  2002-12       Impact factor: 3.982

9.  Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma.

Authors:  J F Henry; L Gramatica; A Denizot; A Kvachenyuk; M Puccini; T Defechereux
Journal:  Langenbecks Arch Surg       Date:  1998-04       Impact factor: 3.445

10.  Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A.

Authors:  S A Wells; D D Chi; K Toshima; L P Dehner; C M Coffin; S B Dowton; J L Ivanovich; M K DeBenedetti; W G Dilley; J F Moley
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

View more
  11 in total

Review 1.  Multiple endocrine neoplasia syndromes, children, Hirschsprung's disease and RET.

Authors:  S W Moore; M G Zaahl
Journal:  Pediatr Surg Int       Date:  2008-03-26       Impact factor: 1.827

2.  Isthmus-preserving total bilobectomy: an adequate operation for C-cell hyperplasia.

Authors:  Robert Arnulf Wahl; Christian Vorländer; Susanne Kriener; Johanna Pedall; Martin Spitza; Martin-Leo Hansmann
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

3.  Searching for non-RET molecular alterations in medullary thyroid carcinoma: expression analysis by mRNA differential display.

Authors:  Thomas J Musholt; Julia Hanack; Christoph Brehm; Reinhard von Wasielewski; Petra B Musholt
Journal:  World J Surg       Date:  2005-04       Impact factor: 3.352

4.  Management of thyroid cancers.

Authors:  Devendra A Chaukar; Anuja D Deshmukh; Mitali R Dandekar
Journal:  Indian J Surg Oncol       Date:  2010-11-21

Review 5.  [Hereditary thyroid cancer].

Authors:  H Dralle; A Machens; K Lorenz
Journal:  Chirurg       Date:  2008-11       Impact factor: 0.955

6.  Codon Y791F mutations in a large kindred: is prophylactic thyroidectomy always indicated?

Authors:  Peter Vestergaard; Else Marie Vestergaard; Helle Brockstedt; Peer Christiansen
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

Review 7.  Genotype-phenotype based surgical concept of hereditary medullary thyroid carcinoma.

Authors:  Andreas Machens; Henning Dralle
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

Review 8.  RET signaling in endocrine tumors: delving deeper into molecular mechanisms.

Authors:  Andrea Z Lai; Taranjit S Gujral; Lois M Mulligan
Journal:  Endocr Pathol       Date:  2007       Impact factor: 3.943

9.  RET mutation Tyr791Phe: the genetic cause of different diseases derived from neural crest.

Authors:  Eliska Vaclavikova; Sarka Dvorakova; Vlasta Sykorova; Radovan Bilek; Katerina Dvorakova; Petr Vlcek; Richard Skaba; Tomas Zelinka; Bela Bendlova
Journal:  Endocrine       Date:  2009-10-14       Impact factor: 3.633

10.  Identification of a secondary RET mutation in a pediatric patient with relapsed acute myeloid leukemia leads to the diagnosis and treatment of asymptomatic metastatic medullary thyroid cancer in a parent: a case for sequencing the germline.

Authors:  Danielle M Pendrick; Jennifer A Oberg; Susan J Hsiao; Wendy K Chung; Carrie Koval; Anthony Sireci; Jennifer H Kuo; Prakash Satwani; Chana L Glasser; Maria Luisa Sulis; Mahesh M Mansukhani; Julia L Glade Bender
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.